Home LiteratureArticle Details
PMID: 14764695 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

NF-kappa B controls cell fate specification, survival, and molecular differentiation of immunoregulatory natural T lymphocytes.

Journal of immunology (Baltimore, Md. : 1950) ·Vol. 172 ·No. 4 ·2004-02-15 ·Pages 2265-73

Stanic AK, Bezbradica JS, Park JJ, Matsuki N, Mora AL, Van Kaer L, Boothby MR, Joyce S

Abstract

Ontogenetic, homeostatic, and functional deficiencies within immunoregulatory natural T (iNKT) lymphocytes underlie various inflammatory immune disorders including autoimmunity. Signaling events that control cell fate specification and molecular differentiation of iNKT cells are only partly understood. Here we demonstrate that these processes within iNKT cells require classical NF-kappaB signaling. Inhibition of NF-kappaB signaling blocks iNKT cell ontogeny at an immature stage and reveals an apparent, novel precursor in which negative selection occurs. Most importantly, this block occurs due to a lack of survival signals, as Bcl-x(L) overexpression rescues iNKT cell ontogeny. Maturation of immature iNKT cell precursors induces Bcl-2 expression, which is defective in the absence of NF-kappaB signaling. Bcl-x(L) overexpression also rescues this maturation-induced Bcl-2 expression. Thus, antiapoptotic signals relayed by NF-kappaB critically control cell fate specification and molecular differentiation of iNKT cells and, hence, reveal a novel role for such signals within the immune system.

MeSH Terms
Animals Antigens/biosynthesis Antigens, Surface Apoptosis/genetics,immunology Cell Differentiation/genetics,immunology Cell Division/genetics,immunology Cell Lineage/genetics,immunology Cell Survival/genetics,immunology Growth Inhibitors/genetics,physiology I-kappa B Proteins/physiology Killer Cells, Natural/cytology,immunology,metabolism Lectins, C-Type Mice Mice, Inbred BALB C Mice, Inbred C57BL Mice, Transgenic NF-KappaB Inhibitor alpha NF-kappa B/antagonists & inhibitors,genetics,physiology NK Cell Lectin-Like Receptor Subfamily B Protein Biosynthesis Proteins Proto-Oncogene Proteins c-bcl-2/biosynthesis,genetics,physiology Signal Transduction/genetics,immunology Stem Cells/cytology,immunology,metabolism T-Lymphocyte Subsets/cytology,immunology,metabolism bcl-X Protein
Chemicals
Antigens Antigens, Surface Bcl2l1 protein, mouse Growth Inhibitors I-kappa B Proteins Lectins, C-Type NF-kappa B NK Cell Lectin-Like Receptor Subfamily B Nfkbia protein, mouse Proteins Proto-Oncogene Proteins c-bcl-2 bcl-X Protein NF-KappaB Inhibitor alpha
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Stanic Aleksandar K
Department of Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Bezbradica Jelena S
Park Jang-June
Matsuki Naoto
Mora Ana L
Van Kaer Luc
Boothby Mark R
Joyce Sebastian
Article Info
Journal
Journal of immunology (Baltimore, Md. : 1950)
Abbr.
J Immunol
ISSN
0022-1767
Published
2004-02-15
Pages
2265-73
Language
English
Region
United States
NLM ID
2985117R
Subset
IM
Grants
NIAID NIH HHS · AI42284 · United States
NIAID NIH HHS · AI49460 · United States
NIAID NIH HHS · AI50953 · United States
NHLBI NIH HHS · HL61752 · United States
NHLBI NIH HHS · HL68744 · United States
NINDS NIH HHS · NS44044 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com